Chemed Co. (NYSE:CHE) Shares Sold by Martingale Asset Management L P

Martingale Asset Management L P decreased its stake in shares of Chemed Co. (NYSE:CHE) by 8.7% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 31,993 shares of the company’s stock after selling 3,067 shares during the quarter. Martingale Asset Management L P’s holdings in Chemed were worth $19,227,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of CHE. GAMMA Investing LLC boosted its stake in Chemed by 34.4% during the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after acquiring an additional 22 shares during the last quarter. Ballentine Partners LLC lifted its position in shares of Chemed by 4.1% in the 3rd quarter. Ballentine Partners LLC now owns 655 shares of the company’s stock worth $394,000 after buying an additional 26 shares during the last quarter. Everpar Advisors LLC lifted its position in shares of Chemed by 4.9% in the 2nd quarter. Everpar Advisors LLC now owns 580 shares of the company’s stock worth $315,000 after buying an additional 27 shares during the last quarter. Creative Planning lifted its position in shares of Chemed by 2.8% in the 2nd quarter. Creative Planning now owns 1,228 shares of the company’s stock worth $667,000 after buying an additional 34 shares during the last quarter. Finally, First Heartland Consultants Inc. lifted its position in shares of Chemed by 7.2% in the 3rd quarter. First Heartland Consultants Inc. now owns 508 shares of the company’s stock worth $305,000 after buying an additional 34 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on CHE. Royal Bank of Canada reduced their price target on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 5th. StockNews.com downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research report on Friday, November 22nd.

Chemed Stock Down 0.4 %

Shares of NYSE:CHE opened at $571.31 on Friday. The company has a market cap of $8.60 billion, a PE ratio of 28.87, a P/E/G ratio of 2.42 and a beta of 0.46. The company’s 50-day moving average price is $578.45 and its 200 day moving average price is $565.06. Chemed Co. has a fifty-two week low of $523.33 and a fifty-two week high of $654.62.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing the consensus estimate of $5.76 by ($0.12). The firm had revenue of $606.18 million during the quarter, compared to the consensus estimate of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $5.32 earnings per share. As a group, equities analysts anticipate that Chemed Co. will post 21.43 EPS for the current year.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Monday, November 18th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, November 18th. This represents a $2.00 annualized dividend and a yield of 0.35%. Chemed’s payout ratio is 10.11%.

Insider Buying and Selling at Chemed

In other news, EVP Nicholas Michael Westfall sold 1,713 shares of Chemed stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $569.35, for a total value of $975,296.55. Following the transaction, the executive vice president now owns 6,109 shares of the company’s stock, valued at $3,478,159.15. The trade was a 21.90 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the completion of the transaction, the chief executive officer now directly owns 103,735 shares in the company, valued at $62,117,555.35. This represents a 1.89 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 6,113 shares of company stock valued at $3,557,445. Company insiders own 3.32% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.